Symptomatic Myocarditis Post COVID-19 Vaccination.

アブストラクト	There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) COVID-19 vaccines. We present a case series of myopericarditis post mRNA (Moderna) and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccines. We intend to highlight the importance of early diagnosis and treatment of vaccine-related myocarditis to reduce mortality and morbidity.
ジャーナル名	Cureus
Pubmed追加日	2022/5/17
投稿者	Patel, Palak; Desai, Dhaval; Ganta, Nagapratap; Tadepalli, Satish; Kata, Priyaranjan; Kanukuntla, Anish; Schoenfeld, Matthew; Sathya, Bharath; Okere, Arthur
組織名	Internal Medicine, Hackensack Meridian Health Ocean University Medical Center,;Brick, USA.;Cardiovascular Disease, Jersey Shore University Medical Center, Neptune, USA.;Internal Medicine, Trinitas Regional Medical Center, Elizabeth, USA.;Internal Medicine, Rutgers Health Community Medical Center, Toms River, USA.;Interventional Cardiology, Jersey Shore University Medical Center, Neptune, USA.;Cardiology, Jersey Shore University Medical Center, Neptune, USA.;Cardiology, Hackensack Meridian Health Ocean University Medical Center, Brick,;USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/35573513/